| 19388128 |
DEVICES FOR KYPHOPLASTY AND METHODS OF USE THEREOF |
Translational And Fundamental Technologies Institute LLC |
GREEN, MICHELLE CHRISTINE |
3773 |
§103 |
Final Rejection |
— |
Pending |
Nov 13, 2025 |
| 19162601 |
MODIFIED NUCLEIC ACID SEQUENCE FOR CONFERRING CLUBROOT RESISTANCE TO CANOLA AND METHODS OF PRODUCING SAME |
The Governors of the University of Alberta |
FAN, WEIHUA |
1663 |
§101§102§112 |
Non-Final OA |
— |
Pending |
Sep 05, 2025 |
| 19312085 |
RECOMBINANT ADENOVIRUSES AND USE THEREOF |
Washington University |
DRISCOLL, LORA E BARNHART |
3991 |
§101DP |
Non-Final OA |
— |
Pending |
Aug 27, 2025 |
| 19289942 |
METHODS AND COMPOSITIONS FOR TREATING EPILEPSY |
Uniqure France |
QIAN, CELINE X |
1637 |
§102DP |
Non-Final OA |
— |
Pending |
Aug 04, 2025 |
| 19265435 |
COMPOUNDS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS |
The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health |
DIAMOND, ALAN D |
3991 |
DP |
Non-Final OA |
— |
Pending |
Jul 10, 2025 |
| 19126720 |
ELECTRONICALLY ENABLED PILL ORGANIZER |
9494-1861 Québec Inc. |
MCCORMACK, THOMAS S |
2686 |
§103 |
Non-Final OA |
— |
Pending |
May 02, 2025 |
| 19181929 |
COMPOSITIONS AND METHODS FOR INDUCING OOCYTE MATURATION |
Gameto, Inc. |
CORDAS, EMILY ANN |
1632 |
§102§103Other |
Non-Final OA |
— |
Pending |
Apr 17, 2025 |
| 19060439 |
CULTURE MEDIA AND CONDITIONS FOR IN VITRO EXPANSION OF HEPATOCYTES |
Satellite Biosciences, Inc. |
TRAN, KHOA NHAT |
1632 |
§102§103 |
Final Rejection |
— |
Pending |
Feb 21, 2025 |
| 18876576 |
COMPOSITIONS AND METHODS FOR THE PURIFICATION OF SQUALENE |
Amyris, Inc. |
FADHEL, ALI Z |
1772 |
§102§103 |
Non-Final OA |
— |
Pending |
Dec 18, 2024 |
| 18980973 |
MULTISENSOR BRACELET |
Legionarius, LLC |
HUNNINGS, TRAVIS R |
2689 |
§102§103 |
Non-Final OA |
22d |
Pending |
Dec 13, 2024 |
| 18853473 |
ADENO-ASSOCIATED VIRUS POTENCY ASSAY AND USES THEREOF |
Astellas Gene Therapies, Inc. |
POPA, ILEANA |
1633 |
§103 |
Non-Final OA |
— |
Pending |
Oct 02, 2024 |
| 18826883 |
METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS |
President and Fellows of Harvard College |
PETTITT, JOHN F |
3763 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 06, 2024 |
| 18843373 |
GPR120 AGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
Dompe' Farmaceutici Spa |
REDWOOD, CHRISTOPHER EVAN |
1629 |
§103§112DP |
Non-Final OA |
— |
Pending |
Sep 03, 2024 |
| 18821656 |
METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA |
Minerva Neurosciences, Inc. |
RODRIGUEZ, RAYNA B |
1628 |
DP |
Non-Final OA |
— |
Pending |
Aug 30, 2024 |
| 18818268 |
ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME |
The General Hospital Corporation |
GUSTILO, ESTELLA M |
1646 |
§103§112Other |
Final Rejection |
72d overdue |
Pending |
Aug 28, 2024 |
| 18841472 |
ORAL PCLX-001 IN THE TREATMENT OF HUMAN CANCER |
Pacylex Pharmaceuticals Inc. |
CORNET, JEAN P |
1628 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Aug 26, 2024 |
| 18838347 |
NEURAL PROGENITOR CELL COMPOSITIONS AND METHODS OF USING THE SAME |
The General Hospital Corporation |
KASAYAN, KATRIEL BARCELLANO |
1634 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Aug 14, 2024 |
| 18572977 |
DEXMECAMYLAMINE AND USES THEREOF |
Atacama Therapeutics, Inc. |
ROCHELLE, CIERRA MARIE |
1627 |
§103 |
Non-Final OA |
— |
Pending |
Aug 13, 2024 |
| 18833242 |
IMIDAZOPYRIDINE INHIBITORS OF TYROSINE KINASE |
Bridgene Biosciences. Inc. |
FETTEROLF, BRANDON J |
1626 |
§112 |
Non-Final OA |
— |
Pending |
Jul 25, 2024 |
| 18769009 |
RAS INHIBITORS |
Revolution Medicines, Inc. |
KIM, SEONG JONG |
1621 |
§112 |
Non-Final OA |
— |
Pending |
Jul 10, 2024 |
| 18764714 |
METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION |
Minerva Neurosciences, Inc. |
NEAGU, IRINA |
1629 |
§103§112 |
Non-Final OA |
— |
Pending |
Jul 05, 2024 |
| 18763519 |
NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES |
Dompe' Farmaceutici Spa |
WANG, CHANG YU |
1675 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Jul 03, 2024 |
| 18724255 |
PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF |
Caregen Co., Ltd. |
COFFA, SERGIO |
1658 |
§102§112 |
Non-Final OA |
— |
Pending |
Jun 26, 2024 |
| 18724352 |
PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF |
Caregen Co., Ltd. |
KONOPELSKI SNAVEL, SARA ELIZABETH |
1658 |
§101§112 |
Non-Final OA |
— |
Pending |
Jun 26, 2024 |
| 18724295 |
PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF |
Caregen Co., Ltd. |
HA, JULIE |
1654 |
§101 |
Non-Final OA |
— |
Pending |
Jun 26, 2024 |
| 18719260 |
METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF |
Alexion Pharmaceuticals, Inc. |
ROMERO, KRISTEN WANG |
1624 |
§102§103Other |
Non-Final OA |
— |
Pending |
Jun 13, 2024 |
| 18719261 |
METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS |
Alexion Pharmaceuticals, Inc. |
BAUER, BRIANNA LEE |
1623 |
§112 |
Non-Final OA |
— |
Pending |
Jun 13, 2024 |
| 18714669 |
METHOD OF GENERATING FUNCTIONAL ISLETS FROM PLURIPOTENT STEM CELLS |
Hangzhou Reprogenix Bioscience, Inc. |
MOSS, NATALIE M |
1653 |
§103§112 |
Non-Final OA |
— |
Pending |
May 30, 2024 |
| 18709255 |
BACTERIAL STRAINS FOR TREATING DISEASE |
Microba Ip Pty Ltd. |
FAN, WEIHUA |
1663 |
§112 |
Final Rejection |
— |
Pending |
May 10, 2024 |
| 18659831 |
PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV |
Hoffmann-La Roche, Inc. |
KONOPKA, CATHERINE ANNE |
1635 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 09, 2024 |
| 18658154 |
SYSTEM FOR DETECTING MICRO-NEUROMAS AND METHODS OF USE THEREOF |
President and Fellows of Harvard College |
SIPES, JOHN CURTIS |
2872 |
Other |
Non-Final OA |
— |
Pending |
May 08, 2024 |
| 18708275 |
FLUID TREATMENT SYSTEM AND RELATED METHODS |
Lignosol Ip Limited |
BUSHEY, CHARLES S |
1776 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 08, 2024 |
| 18655854 |
COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION |
Thomas Jefferson University |
LEE, ANDREW P |
1691 |
§102§103 |
Non-Final OA |
— |
Pending |
May 06, 2024 |
| 18707478 |
METHODS FOR DEFINING STAGES AND PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS |
The General Hospital Corporation |
CHERNYSHEV, OLGA N |
|
§101§112 |
Non-Final OA |
— |
Pending |
May 03, 2024 |
| 18653106 |
METHODS OF TREATING CANCER |
Inspirna, Inc. |
HUTTER, GILLIAN A |
1625 |
§103DP |
Non-Final OA |
— |
Pending |
May 02, 2024 |
| 18706302 |
DETECTION, STAGING, MONITORING AND TREATING A DISEASE OR A CONDITION |
Sunbird Bio, Inc. |
BOWERS, ERIN M |
1653 |
§102Other |
Non-Final OA |
20d |
Pending |
Apr 30, 2024 |
| 18647374 |
SIGMA LIGAND COMPOUNDS AND USES THEREOF |
Minerva Neurosciences, Inc. |
RICCI, CRAIG D |
1611 |
§112 |
Non-Final OA |
— |
Pending |
Apr 26, 2024 |
| 18645535 |
FUNCTIONAL EEG MONTAGE FOR COGNITIVE SKILL DEVELOPMENT |
Thynk, Inc. |
JANG, CHRISTIAN Y |
3791 |
§103§112 |
Non-Final OA |
— |
Pending |
Apr 25, 2024 |
| 18646092 |
ENGINEERED TISSUE CONSTRUCTS AND USES THEREOF |
Satellite Biosciences, Inc. |
PELLEGRINO, BRIAN E |
3799 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Apr 25, 2024 |
| 18704122 |
CULTURE MEDIA AND CONDITIONS FOR IN VITRO EXPANSION AND/OR MATURATION OF HEPATOCYTES |
Satellite Biosciences, Inc. |
GU, QINHUA |
1633 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Apr 24, 2024 |
| 18634289 |
CRYSTALLINE FORMS OF RAS INHIBITORS, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USE THEREOF |
Revolution Medicines, Inc. |
INAM, SAHAR |
1622 |
§103 |
Non-Final OA |
— |
Pending |
Apr 12, 2024 |
| 18634241 |
GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR THE TREATMENT OF ENDOMETRIOSIS |
Kissei Pharmaceutical Co., Ltd. |
HUI, SAN MING R |
1627 |
§103DP |
Non-Final OA |
— |
Pending |
Apr 12, 2024 |
| 18698176 |
OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING INFLAMMATORY LUNG DISEASES |
DSM Nutritional Products, LLC |
LAU, JONATHAN S |
1693 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Apr 03, 2024 |
| 18697064 |
KITS AND METHODS FOR PREPARATION OF NUCLEIC ACID LIBRARIES FOR SEQUENCING |
Seqwell, Inc. |
RAYMONDA, MATTHEW HAROLD |
|
§103§112 |
Non-Final OA |
— |
Pending |
Mar 29, 2024 |
| 18695095 |
METHODS OF EDITING NUCLEIC ACID SEQUENCES |
UNITED KINGDOM RESEARCH AND INNOVATION |
WARD, AARON DUREL |
|
§102§103§112Other |
Non-Final OA |
— |
Pending |
Mar 25, 2024 |
| 18693722 |
PLATFORMS FOR DRUG TESTS AGAINST SYNUCLEINOPATHY USING HUMAN BRAIN ORGANOIDS |
Okinawa Institute Of Science And Technology School Corporation |
ROGERS, ERIC JASON |
1638 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Mar 20, 2024 |
| 18605744 |
ASSAYS FOR ALPHA-DYSTROGLYCAN GLYCOSYLATION AND METHODS FOR USING SAME |
Bridgebio Services Inc. |
MONTGOMERY, ANN Y |
1678 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Mar 14, 2024 |
| 18691738 |
SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER |
The Governors of the University of Alberta |
PROSSER, ALISSA J |
1619 |
§103§112 |
Non-Final OA |
53d |
Pending |
Mar 13, 2024 |
| 18691764 |
SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING |
UTI LIMITED PARTNERSHIP |
HAILEY, PATRICIA L |
1732 |
§102§112 |
Non-Final OA |
— |
Pending |
Mar 13, 2024 |
| 18602622 |
GENE THERAPY FOR TUBEROUS SCLEROSIS |
The General Hospital Corporation |
VIVLEMORE, TRACY ANN |
1638 |
§102§112DP |
Non-Final OA |
— |
Pending |
Mar 12, 2024 |
| 18690028 |
PROCESS FOR FORMULATING COMPOSITIONS COMPRISING GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |
Zealand Pharma A/S |
REYNOLDS, FRED H |
1658 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Mar 07, 2024 |
| 18688617 |
METHODS OF PRODUCING HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF |
Amyris, Inc. |
MOEHLMAN, ANDREW TERRY |
1655 |
§103§112 |
Non-Final OA |
— |
Pending |
Mar 01, 2024 |
| 18688518 |
METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS |
The General Hospital Corporation |
RIVERA-MARTINEZ, GUILLERMO M |
2677 |
§112 |
Final Rejection |
22d overdue |
Pending |
Mar 01, 2024 |
| 18688026 |
DOSAGE REGIME |
Zealand Pharma A/S |
COFFA, SERGIO |
1658 |
§103 |
Final Rejection |
— |
Pending |
Feb 29, 2024 |
| 18686799 |
INDUCED TOTIPOTENT STEM CELLS AND PREPARATION METHOD THEREFOR |
Tsinghua University |
PENNINGTON, KATIE LEIGH |
1634 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
Feb 26, 2024 |
| 18686817 |
ANTI-CLDN-18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF |
Shanghai Junshi Biosciences Co., Ltd. |
CHATTIN, AMY MARIE |
1643 |
§112DP |
Non-Final OA |
— |
Pending |
Feb 26, 2024 |
| 18684449 |
LONG-LIVED REDOX-ACTIVE MOLECULES WITH LOW REDOX POTENTIAL |
President and Fellows of Harvard College |
KOROVINA, ANNA |
1729 |
§102§103 |
Non-Final OA |
— |
Pending |
Feb 16, 2024 |
| 18684014 |
COMPOSITIONS CONTAINING POLYNUCLEOTIDE AMPHIPHILES AND METHODS OF USE THEREOF |
Elicio Therapeutics, Inc. |
HUDSON, AMY ROSE |
1636 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Feb 15, 2024 |
| 18683728 |
PREPARATION OF LIBRARIES OF PROTEIN VARIANTS EXPRESSED IN EUKARYOTIC CELLS |
Iontas Limited |
FLINDERS, JEREMY C |
1684 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Feb 14, 2024 |
| 18681396 |
SALT TOLERANT PLANTS |
Rory James Hornby |
PAGE, BRENT T |
1663 |
§112 |
Non-Final OA |
— |
Pending |
Feb 05, 2024 |
| 18427351 |
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE |
Invetx, Inc. |
DAHLE, CHUN WU |
1641 |
§102§112 |
Non-Final OA |
— |
Pending |
Jan 30, 2024 |
| 18267379 |
PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR |
Institute Of Biophysics, Chinese Academy Of Sciences |
WANG, RUIXUE |
1672 |
§103§112Other |
Final Rejection |
— |
Pending |
Jan 08, 2024 |
| 18577369 |
COMPOSITIONS AND METHODS FOR ACTIVATING A NEURAL RECEPTOR |
Gila Therapeutics, Inc. |
CHERNYSHEV, OLGA N |
1675 |
§101§102§112DP |
Non-Final OA |
— |
Pending |
Jan 08, 2024 |
| 18574221 |
MIGRATION OF HUMAN PERIPHERAL LEUKOCYTES IN RESPONSE TO CHEMOTACTIC FACTORS DURING PREGNACY |
The Governors of the University of Alberta |
OGUNTADE, ELIZABETH BISOLA |
1654 |
§101§103§112DP |
Non-Final OA |
— |
Pending |
Dec 26, 2023 |
| 18396160 |
POLYPEPTIDES WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) AND METHODS OF USE |
Invetx, Inc. |
BENAVIDES, JENNIFER ANN |
1675 |
§103DP |
Non-Final OA |
— |
Pending |
Dec 26, 2023 |
| 18393145 |
Preparation Method and Enrichment Method for Cyanidin-3-Diglucoside-5-Glucoside |
China Agricultural University |
SWIFT, CANDICE LEE |
1657 |
§103§112Other |
Final Rejection |
22d |
Pending |
Dec 21, 2023 |
| 18571567 |
PRODUCTION OF HALOGENATED ALKOXYETHANE |
Commonwealth Scientific And Industrial Research Organisaton |
BAHTA, MEDHANIT W |
1692 |
§102§103 |
Non-Final OA |
— |
Pending |
Dec 18, 2023 |
| 18571585 |
SYNTHESIS OF HALOGENATED ALKOXYETHANE |
Commonwealth Scientific And Industrial Research Organisation |
MURESAN, ANA Z |
1692 |
§103 |
Non-Final OA |
— |
Pending |
Dec 18, 2023 |
| 18516366 |
PROTEIN PROSTHESES FOR MITOCHONDRIAL DISEASES OR CONDITIONS |
The General Hospital Corporation |
WEHBE, ANNE MARIE SABRINA |
1634 |
§112 |
Final Rejection |
— |
Pending |
Nov 21, 2023 |
| 18561964 |
METHODS OF ENRICHING FOR CIRCULAR POLYRIBONUCLEOTIDES |
Flagship Pioneering Innovations Vi, LLC |
RAVINDRA, KRISHNA NUGGEHALLI |
1636 |
§103§112 |
Non-Final OA |
— |
Pending |
Nov 17, 2023 |
| 18289801 |
COMBINATION OF PRAME SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS |
Medigene Immunotherapies GmbH |
BUNNER, BRIDGET E |
1647 |
§103DP |
Non-Final OA |
— |
Pending |
Nov 07, 2023 |
| 18288870 |
KETAMINE AND CANNABIS FOR THE TREATMENT OF EMOTIONAL DISORDERS |
Progressive Therapeutics Inc. |
MELLER, MICHAEL V |
1655 |
§102§103 |
Non-Final OA |
— |
Pending |
Oct 30, 2023 |
| 18288239 |
ULTRA-STRONG HYDROGEL FIBERS |
UTI LIMITED PARTNERSHIP |
JONES, KOLTON ED |
1763 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 25, 2023 |
| 18287963 |
TISSUE-TARGETED MODIFIED AAV CAPSIDS AND METHODS OF USE THEREOF |
Astellas Gene Therapies, Inc. |
ALLEN, MICHAEL D |
1671 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 23, 2023 |
| 18287793 |
NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS |
The Queensland Institute of Medical Research |
BANERJEE, KOYELI |
1658 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 20, 2023 |
| 18030740 |
BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA |
Wörwag Pharma GmbH & Co.Kg |
CHANDRAKUMAR, NIZAL S |
1625 |
§103 |
Non-Final OA |
— |
Pending |
Oct 16, 2023 |
| 18285899 |
METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS |
President and Fellows of Harvard College |
PETTITT, JOHN F |
3763 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 06, 2023 |
| 18285697 |
LIGNIN-BASED COMPOSITIONS AND RELATED HEAVY METAL RECOVERY METHODS |
Lignosol Ip Limited |
ZHANG, KELING NMN |
1732 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 05, 2023 |
| 18284951 |
COMBINATION THERAPY FOR COVID-19 VACCINATION |
Dompe' Farmaceutici Spa |
ALAM, DANYAL HASSAN |
1672 |
§103§112 |
Final Rejection |
— |
Pending |
Sep 29, 2023 |
| 18551955 |
METHOD FOR MANUFACTURING LAMINATE |
Namics Corporation |
WITTENBERG, STEFANIE S |
1795 |
§103 |
Final Rejection |
— |
Pending |
Sep 22, 2023 |
| 18282443 |
MEC SYSTEM |
Electrochaea GmbH |
KEELING, ALEXANDER W |
1795 |
§103 |
Non-Final OA |
— |
Pending |
Sep 15, 2023 |
| 18281346 |
COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY |
Audentes Therapeutics, Inc. |
DITMER, KATHRYN ELIZABETH |
3785 |
§103§112 |
Non-Final OA |
19d |
Pending |
Sep 11, 2023 |
| 18281025 |
PROFILING EPIGENETIC AGE IN SINGLE CELLS AND WITH LOW-PASS SEQUENCING DATA |
The Brigham And Women'S Hospital, Inc. |
ELKINS, BLAKE HARRISON |
1687 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Sep 08, 2023 |
| 18280325 |
TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS |
Technische Universität München |
NEAGU, IRINA |
1629 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Sep 05, 2023 |
| 18279708 |
CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES |
Dompe' Farmaceutici Spa |
DAHLIN, HEATHER RAQUEL |
1629 |
§102§103DP |
Final Rejection |
15d |
Pending |
Aug 31, 2023 |
| 18279517 |
THE USE OF EMPAGLIFLOZIN FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE |
The Governors of the University of Alberta |
SCHACHERMEYER, SAMANTHA LYNN |
1693 |
§103 |
Final Rejection |
46d overdue |
Pending |
Aug 30, 2023 |
| 18547164 |
PHARMACEUTICAL COMPOSITIONS COMPRISING RANPIRNASE |
Okogen, Inc. |
SWIFT, CANDICE LEE |
1657 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Aug 21, 2023 |
| 18275849 |
NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES |
Dompe' Farmaceutici Spa |
FORD, VANESSA L |
1674 |
§102§112 |
Non-Final OA |
— |
Pending |
Aug 04, 2023 |
| 18228818 |
COMPOSITE EMBOLIZATION BEADS |
Translational And Fundamental Technologies Institute LLC |
TRAN, LARA LINH |
3791 |
§102§103 |
Non-Final OA |
— |
Pending |
Aug 01, 2023 |
| 18275195 |
COMPOSITION FOR TREATING SHORT BOWEL SYNDROME |
Zealand Pharma A/S |
NIEBAUER, RONALD T |
1658 |
§103Other |
Final Rejection |
— |
Pending |
Jul 31, 2023 |
| 17625380 |
MAGEA10 SPECIFIC T CELL RECEPTORS AND THEIR USE |
Medigene Immunotherapies GmbH |
ALLEN, MARIANNE P |
1647 |
§103§112 |
Final Rejection |
17d overdue |
Pending |
Jul 27, 2023 |
| 18273395 |
ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES |
The General Hospital Corporation |
LEE, YIE CHIA |
1642 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Jul 20, 2023 |
| 18273121 |
METHODS OF MITIGATING MYOCARDIAL DAMAGE DUE TO EXTRACORPOREAL MEMBRANE OXYGENATION |
Tufts Medical Center, Inc. |
WEHRHEIM, LINDSEY GAIL |
3799 |
§102 |
Non-Final OA |
— |
Pending |
Jul 19, 2023 |
| 17910686 |
GENE THERAPY OF NIEMANN-PICK DISEASE TYPE C |
UCL Business Ltd |
ABBOTT, KODYE LEE |
1634 |
§103§112 |
Non-Final OA |
— |
Pending |
Jun 16, 2023 |
| 18256304 |
METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB |
Hht Foundation International, Inc. |
WORSHAM, JESSICA N |
1615 |
§103 |
Non-Final OA |
83d |
Pending |
Jun 07, 2023 |
| 18039992 |
Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists |
Zealand Pharma A/S |
FISCHER, JOSEPH |
1658 |
§103Other |
Final Rejection |
4d overdue |
Pending |
Jun 02, 2023 |
| 18039812 |
RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1 |
Astellas Gene Therapies, Inc. |
VIJAYARAGHAVAN, JAGAMYA NMN |
1633 |
§103§112 |
Non-Final OA |
31d overdue |
Pending |
Jun 01, 2023 |
| 18039813 |
RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING CAG REPEAT DISEASES |
Astellas Gene Therapies, Inc. |
VIJAYARAGHAVAN, JAGAMYA NMN |
1637 |
§103§112DP |
Non-Final OA |
— |
Pending |
Jun 01, 2023 |
| 18326661 |
SEGMENTED GASTROINTESTINAL DEVICES AND METHODS OF USE THEREOF |
Morphic Medical, Inc. |
YANG, CHENG FONG |
3781 |
§103 |
Final Rejection |
37d overdue |
Pending |
May 31, 2023 |
| 18201498 |
PREFERRED ORAL TESTOSTERONE UNDECANOATE THERAPY TO ACHIEVE TESTOSTERONE REPLACEMENT TREATMENT |
Marius Pharmaceuticals, Inc. |
MOU, LIYUAN |
1628 |
§103§112Other |
Final Rejection |
18d overdue |
Pending |
May 24, 2023 |
| 18199415 |
METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS |
Trailhead Biosystems Inc. |
STAVROU, CONSTANTINA E |
1632 |
§112 |
Final Rejection |
— |
Pending |
May 19, 2023 |
| 18037795 |
Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists |
Zealand Pharma A/S |
KONOPELSKI SNAVEL, SARA ELIZABETH |
1658 |
§103DP |
Final Rejection |
— |
Pending |
May 19, 2023 |
| 18037597 |
COMPUTER PROGRAM FOR TRAINING A NEUROLOGICAL CONDITION DETECTION ALGORITHM, METHOD OF PROGRAMMING AN IMPLANTABLE NEUROSTIMULATION DEVICE AND COMPUTER PROGRAM THEREFOR |
Precisis GmbH |
SCHLUETER, MARY GRACE |
3796 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 18, 2023 |
| 18037196 |
CYCLOTRON TARGET AND LANTHANUM THERANOSTIC PAIR FOR NUCLEAR MEDICINE |
The Governors of the University of Alberta |
DAVIS, SHARON M |
3646 |
§103 |
Non-Final OA |
35d overdue |
Pending |
May 16, 2023 |
| 18037117 |
SYSTEM FOR SENSING EEG SIGNALS ON A LIVING BEING, AND SYSTEM FOR ELECTRICALLY STIMULATING TISSUE OF A LIVING BEING |
Precisis GmbH |
BERHANU, ETSUB D |
3791 |
§101§103§112 |
Final Rejection |
76d |
Pending |
May 16, 2023 |
| 18036720 |
METHODS FOR PURIFYING INTER-ALPHA INHIBITOR PROTEINS |
Prothera Biologics, Inc. |
WALLENHORST, MAUREEN |
1797 |
§112 |
Non-Final OA |
— |
Pending |
May 12, 2023 |
| 18196538 |
MIR-375- AND MIR-1-REGULATED COXSACKIEVIRUS B3 HAS NO PANCREAS AND HEART TOXICITY BUT STRONG ANTITUMOR EFFICIENCY IN COLORECTAL CARCINOMAS |
Technische Universität Berlin |
SPENCE, JENNIFER SUZANNE |
1633 |
§103 |
Final Rejection |
— |
Pending |
May 12, 2023 |
| 18035582 |
POLYSACCHARIDES FOR IV ADMINISTRATION THAT TREAT SARS-COV-2 INFECTIONS |
Pharmalectin, Inc. |
CHO, DAVID H |
1693 |
§103§112DP |
Non-Final OA |
— |
Pending |
May 05, 2023 |
| 18035442 |
FILTER UNIT, TEXTILE TREATMENT APPARATUS AND METHOD |
Xeros Limited |
KURTZ, BENJAMIN M |
1711 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 04, 2023 |
| 18140141 |
METHODS OF TREATING LYMPHOPENIA |
Keros Therapeutics, Inc. |
KAUFMAN, CLAIRE M |
1674 |
§102§103§112 |
Non-Final OA |
60d |
Pending |
Apr 27, 2023 |
| 18030876 |
PEPTIDE INHIBITORS OF GLIOMA-ASSOCIATED ONCOGENE DERIVED FROM THE COILED-COIL DIMERIZATION DOMAIN OF Kif7 |
The General Hospital Corporation |
REYNOLDS, FRED H |
1658 |
§101§112 |
Non-Final OA |
— |
Pending |
Apr 07, 2023 |
| 18030858 |
POLAR LIQUIDS WITH HIGH POROSITY AND USES THEREOF |
President and Fellows of Harvard College |
SMARI, ABDUL-RAHMAN YUSUF WALEED |
1736 |
§102§103 |
Non-Final OA |
13d |
Pending |
Apr 07, 2023 |
| 18028025 |
PRAME SPECIFIC T-CELL RECEPTORS AND USES THEREOF |
Medigene Immunotherapies GmbH |
BUTTICE, AUDREY L |
1647 |
§112 |
Final Rejection |
97d overdue |
Pending |
Mar 23, 2023 |
| 18027506 |
PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS |
Achillion Pharmaceuticals, Inc. |
ANDERSON, REBECCA L |
1626 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Mar 21, 2023 |
| 18026921 |
METHOD FOR EXTRACTION OF COINAGE METALS |
Excir Works Corp. |
CARDA, DANIELLE MARIE |
1738 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Mar 17, 2023 |
| 18044747 |
RIBITOL TREATMENT |
The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health |
NEAGU, IRINA |
1629 |
§103§112DP |
Non-Final OA |
— |
Pending |
Mar 09, 2023 |
| 18025343 |
SEQUENCING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF |
Seqwell, Inc. |
BOESEN, CHRISTIAN C |
1684 |
§102 |
Non-Final OA |
— |
Pending |
Mar 08, 2023 |
| 18024624 |
PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY |
Dompe' Farmaceutici Spa |
KONOPELSKI SNAVEL, SARA ELIZABETH |
1658 |
§101§102§103§112 |
Non-Final OA |
5d |
Pending |
Mar 03, 2023 |
| 18024182 |
COMPOSITIONS AND METHODS FOR TREATING THERAPY RESISTANT CANCER |
The General Hospital Corporation |
SHIN, DANA H |
1635 |
§102§103 |
Non-Final OA |
— |
Pending |
Mar 01, 2023 |
| 18024179 |
METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS |
The General Hospital Corporation |
TRAN, DUY ANH |
2674 |
§101§102§103Other |
Non-Final OA |
132d overdue |
Pending |
Mar 01, 2023 |
| 18175225 |
METHOD OF TREATMENT OF PATIENTS HAVING REDUCED SENSITIVITY TO A BCL-2 INHIBITOR |
The Regents of the University of Colorado |
KAUFMAN, CLAIRE M |
1674 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Feb 27, 2023 |
| 18175224 |
FILTRATION-BASED METHODS FOR PREPARING FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING |
Kellbenx Incorported |
KIRWIN, STEFANIE JOHANNA |
1684 |
§103 |
Non-Final OA |
— |
Pending |
Feb 27, 2023 |
| 18021979 |
PEPTIDE FOR THERAPEUTIC APPLICATIONS IN THE DERMATOLOGICAL FIELD |
Dompe' Farmaceutici S.p.A. |
DONOGHUE, BRITTNEY ERIN |
1675 |
§102§103 |
Final Rejection |
14d |
Pending |
Feb 17, 2023 |
| 18168028 |
USE OF ROLUPERIDONE IN PREVENTING RELAPSE IN SCHIZOPHRENIA PATIENTS |
Minerva Neurosciences, Inc. |
NOLAN, JASON MICHAEL |
1623 |
§103§112 |
Non-Final OA |
— |
Pending |
Feb 13, 2023 |
| 18165613 |
CELL MEMBRANE PENETRATING CONJUGATES |
Cygenica Limited |
VARADARAJ, ARCHANA |
1658 |
§101§102§103Other |
Non-Final OA |
56d overdue |
Pending |
Feb 07, 2023 |
| 18019166 |
METHODS FOR LEACHING AND RECOVERY OF PLATINUM GROUP METALS IN ORGANIC SOLVENTS |
Excir Works Corp. |
MCGUTHRY BANKS, TIMA MICHELE |
1733 |
§112 |
Final Rejection |
53d |
Pending |
Feb 01, 2023 |
| 18157453 |
TREATMENT OF PELVIC ORGAN PROLAPSE |
Remendium Labs LLC |
KREMER, MATTHEW |
3791 |
§112 |
Non-Final OA |
— |
Pending |
Jan 20, 2023 |
| 18016490 |
INHIBITORS OF COMPLEMENT FACTOR C3 AND THEIR MEDICAL USES |
Zp Spv 3 K/S |
DABKOWSKI, ERINNE R |
1654 |
§103§112DP |
Non-Final OA |
— |
Pending |
Jan 17, 2023 |
| 18154241 |
METHODS AND COMPOSITIONS FOR TREATING EPILEPSY |
Uniqure France |
CHONG, KIMBERLY |
1636 |
§112 |
Final Rejection |
— |
Pending |
Jan 13, 2023 |
| 18002368 |
METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTI-TL1A ANTIBODIES |
Pfizer, Inc. |
KAUFMAN, CLAIRE M |
1674 |
§103§112 |
Non-Final OA |
— |
Pending |
Dec 19, 2022 |
| 18071388 |
METHODS AND COMPOSITIONS FOR MAINTAINING AND EXPANDING HEMATOPOIETIC STEM CELLS |
Trailhead Biosystems Inc. |
TAKENAKA, RISA |
1632 |
§103 |
Final Rejection |
31d overdue |
Pending |
Nov 29, 2022 |
| 17926106 |
IMMUNE CELLS WITH ENHANCED FUNCTION |
The Queensland Institute of Medical Research |
VAN BUREN, LAUREN K |
1638 |
§102§103 |
Non-Final OA |
— |
Pending |
Nov 17, 2022 |
| 17924578 |
COMPOSITIONS AND METHODS FOR PROMOTING HAIR CELL REGENERATION |
Decibel Therapeutics, Inc. |
SINGH, ANOOP KUMAR |
1632 |
§102§103§112 |
Final Rejection |
— |
Pending |
Nov 10, 2022 |
| 17924425 |
POLYNUCLEOTIDE ARRAYS |
Oxford University Innovation Limited |
ZHANG, KAIJIANG |
1684 |
§102 |
Final Rejection |
30d overdue |
Pending |
Nov 10, 2022 |
| 17920088 |
HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION |
Massachusetts Eye And Ear Infirmary |
SPENCER, ANDREA LYNNE MORRIS |
1631 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 20, 2022 |
| 17996577 |
TREATMENT OF VIRAL CONJUNCTIVITIS |
Okogen, Inc. |
FAN, LYNN Y |
1759 |
§103 |
Final Rejection |
— |
Pending |
Oct 19, 2022 |
| 17906631 |
RIBONUCLEASES FOR TREATING VIRAL INFECTIONS |
Okogen, Inc. |
SIFFORD, JEFFREY MARK |
1671 |
§101§103§112Other |
Non-Final OA |
— |
Pending |
Sep 19, 2022 |
| 17905081 |
PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE |
Biosergen AS |
GALSTER, SAMUEL LEONARD |
1693 |
§103§112 |
Final Rejection |
— |
Pending |
Aug 26, 2022 |
| 17896781 |
Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons |
Trailhead Biosystems Inc. |
SPENCER, ANDREA LYNNE MORRIS |
1631 |
§103§112 |
Final Rejection |
14d |
Pending |
Aug 26, 2022 |
| 17800639 |
CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOF |
Dompe' Farmaceutici Spa |
LEE, ANDREW P |
1691 |
§103 |
Non-Final OA |
19d overdue |
Pending |
Aug 18, 2022 |
| 17819591 |
PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE |
Prothera Biologics, Inc. |
ORWIG, KEVIN S |
3991 |
§103DP |
Non-Final OA |
16d overdue |
Pending |
Aug 12, 2022 |
| 17798344 |
ACTIVATION OF NEUROPEPTIDE RECEPTORS ON PLASMACYTOID DENDRITIC CELLS TO TREAT OR PREVENT OCULAR DISEASES ASSOCIATED WITH NEOVASCULARIZATION AND INFLAMMATION |
Trustees Of Tufts College |
HUANG, GIGI GEORGIANA |
1613 |
§102§103 |
Final Rejection |
— |
Pending |
Aug 09, 2022 |
| 17798334 |
CELL CULTURE MANAGEMENT SYSTEM |
Integriculture Inc. |
KRCHA, MATTHEW D |
1796 |
§102§112 |
Non-Final OA |
42d |
Pending |
Aug 09, 2022 |
| 17810022 |
METHODS FOR THE TREATMENT OF EPILEPSY |
Centre National De La Recherche Scientifique |
MEYERING, SHABANA SHABBEER |
1635 |
§103 |
Non-Final OA |
21d |
Pending |
Jun 30, 2022 |
| 17786360 |
PREPARATION OF HALOGENATED ALKOXYETHANE |
Commonwealth Scientific And Industrial Research Organisation |
BAHTA, MEDHANIT W |
1692 |
§103 |
Final Rejection |
93d overdue |
Pending |
Jun 16, 2022 |
| 17831012 |
COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS |
Tufts Medical Center, Inc. |
JACKSON-TONGUE, LAKIA J |
1645 |
§102§112Other |
Non-Final OA |
— |
Pending |
Jun 02, 2022 |
| 17781989 |
METHODS FOR DUAL DNA/PROTEIN TAGGING OF OPEN CHROMATIN |
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. |
FLINDERS, JEREMY C |
1684 |
§112 |
Final Rejection |
— |
Pending |
Jun 02, 2022 |
| 17748323 |
METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS |
Trailhead Biosystems Inc. |
TRAN, KHOA NHAT |
1632 |
§103 |
Final Rejection |
10d overdue |
Pending |
May 19, 2022 |
| 17774338 |
DIAGNOSIS AND TREATMENT OF NAFLD AND LIVER FIBROSIS |
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. |
WALLENHORST, MAUREEN |
1797 |
§101§112 |
Non-Final OA |
— |
Pending |
May 04, 2022 |
| 17733509 |
GASTROINTESTINAL IMPLANT DELIVERY SYSTEMS AND METHODS |
Gi Dynamics, Inc. |
ALEMAN, SARAH WEBB |
3774 |
§103 |
Final Rejection |
— |
Pending |
Apr 29, 2022 |
| 17731112 |
METHODS FOR ELECTRO-MECHANICAL TRANSFECTION |
Kytopen Corporation |
NOBLE, MARCIA STEPHENS |
1632 |
§101§102§112Other |
Non-Final OA |
9d |
Pending |
Apr 27, 2022 |
| 17771524 |
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE |
Orchard Therapeutics (Europe) Limited |
PERSONS, JENNA L |
1637 |
§103§112 |
Final Rejection |
— |
Pending |
Apr 25, 2022 |
| 17768300 |
COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS |
Orchard Therapeutics (Europe) Limited |
NOBLE, MARCIA STEPHENS |
1632 |
§102§112 |
Non-Final OA |
30d |
Pending |
Apr 12, 2022 |
| 17765620 |
DIAGNOSIS AND TREATMENT OF THYROID CANCER |
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. |
GIAMMONA, FRANCESCA FILIPPA |
1681 |
§103 |
Non-Final OA |
— |
Pending |
Mar 31, 2022 |
| 17764003 |
METHODS FOR TREATING HYPERPHENYLALANINEMIA |
Ptc Therapeutics Mp, Inc. |
GAUGER, PAUL RANDALL |
1629 |
§103DP |
Final Rejection |
34d |
Pending |
Mar 25, 2022 |
| 17689117 |
METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY |
The General Hospital Corporation |
ABBAS, SYED JARAR |
1645 |
§102§112 |
Non-Final OA |
14d |
Pending |
Mar 08, 2022 |
| 17637392 |
COMPSTATIN ANALOGUES AND THEIR MEDICAL USES |
Zp Spv 3 K/S |
COFFA, SERGIO |
1658 |
§103 |
Non-Final OA |
3d overdue |
Pending |
Feb 22, 2022 |
| 17629918 |
ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT OR TREAT HAIR LOSS |
Tufts Medical Center, Inc. |
MIANO, JOSEPH PAUL |
1631 |
§102§103§112 |
Final Rejection |
134d overdue |
Pending |
Jan 25, 2022 |
| 17629313 |
PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF |
Caregen Co., Ltd. |
NIEBAUER, RONALD T |
1658 |
§101§112 |
Final Rejection |
3d overdue |
Pending |
Jan 21, 2022 |
| 17628617 |
COSMETIC COMPOSITIONS AND USES THEREOF |
Alumier Labs, Inc. |
JOHNSON, DANIELLE D |
1617 |
§103§112 |
Final Rejection |
57d |
Pending |
Jan 20, 2022 |
| 17627975 |
SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER |
The General Hospital Corporation |
LEE, YIE CHIA |
1642 |
§103§112Other |
Final Rejection |
78d |
Pending |
Jan 18, 2022 |
| 17625425 |
LONGEVITY SIGNATURES AND THEIR APPLICATIONS |
The Brigham And Women'S Hospital, Inc. |
MCMILLIAN, KARA RENITA |
1623 |
§102§112 |
Final Rejection |
— |
Pending |
Jan 07, 2022 |
| 17597351 |
METHODS FOR THE TREATMENT OF EPILEPSY |
Centre National De La Recherche Scientifique |
MEYERING, SHABANA SHABBEER |
1635 |
§103 |
Final Rejection |
5d |
Pending |
Jan 04, 2022 |
| 17596491 |
TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF |
The Governors of the University of Alberta |
MARTIN, KEVIN STEPHEN |
1624 |
§102§112 |
Final Rejection |
— |
Pending |
Dec 10, 2021 |
| 17427453 |
ANTIMICROBIAL ENDOLYSIN POLYPEPTIDES, COMPOSITIONS AND FORMULATIONS |
Axitan Holdings, Inc. |
HELLMAN, KRISTINA M |
1654 |
§112 |
Final Rejection |
7d |
Pending |
Jul 30, 2021 |
| 17413223 |
COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE ROUND WINDOW MEMBRANE |
Decibel Therapeutics, Inc. |
REYNOLDS, FRED H |
1658 |
§103 |
Non-Final OA |
28d |
Pending |
Jun 11, 2021 |
| 17292107 |
PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL |
Neurimmune AG |
LEVIN, JOEL D |
1633 |
§103 |
Final Rejection |
28d |
Pending |
May 07, 2021 |
| 17279691 |
FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |
Zealand Pharma A/S |
BEANE, RANDALL L |
1654 |
§103 |
Final Rejection |
29d |
Pending |
Mar 25, 2021 |
| 17275266 |
NANOPARTICLE FORMULATIONS AND METHODS OF THEIR USE |
Children'S Medical Center Corporation |
WAX, ROBERT A |
1615 |
§103 |
Non-Final OA |
— |
Pending |
Mar 11, 2021 |
| 17257055 |
COMPOSITIONS AND METHODS FOR REDUCTION OF LIPOPROTEIN A FORMATION AND TREATMENT OF AORTIC VALVE SCLEROSIS AND AORTIC STENOSIS |
Abcentra, LLC |
FONTAINHAS, AURORA M |
1675 |
§103 |
Final Rejection |
22d |
Pending |
Dec 30, 2020 |
| 16960221 |
PROTON COUPLED ELECTROCHEMICAL CO2 CAPTURE SYSTEM |
President and Fellows of Harvard College |
KOLTONOW, ANDREW ROBERT |
1795 |
§103§112 |
Non-Final OA |
— |
Pending |
Jul 06, 2020 |
| 16610357 |
DEVICES AND METHODS FOR SENSOR-ENHANCED NEEDLE PLACEMENT |
Rockport Medical Technologies LLC |
DARB, HAMZA A. |
3783 |
§103 |
Non-Final OA |
77d overdue |
Pending |
Nov 01, 2019 |
| 16319849 |
PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES |
Cerapedics, Inc. |
LEE, JIA-HAI |
1658 |
§103DP |
Final Rejection |
— |
Pending |
Jan 23, 2019 |
Prosecution Insights